Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description No. ───────────────────────────────────────────────────────────────────── 104 Cover Page Interactive The schedules to this Exhibit have SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Apimeds Pharmaceuticals US, Inc. Date: April 9, 2026 By: /s/ Name: Dr. Vin Menon Title: Chief Executive Officer